Restenosis following coronary angioplasty: clinical presentations and therapeutic options (Q40975043)

25 September 2017

1 reference

title

Restenosis following coronary angioplasty: clinical presentations and therapeutic options (English)

1 reference

25 September 2017

Levine GN

1

1 reference

25 September 2017

Chodos AP

series ordinal

2

1 reference

25 September 2017

Loscalzo J

series ordinal

3

1 reference

25 September 2017

publication date

1 December 1995

1 reference

25 September 2017

1 reference

25 September 2017

volume

18

1 reference

25 September 2017

issue

12

1 reference

25 September 2017

page(s)

693-703

1 reference

Defining coronary restenosis. Newer clinical and angiographic paradigms

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181203

Restenosis and repeat coronary angioplasty in Geneva

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181203

Incidence of restenosis after successful coronary angioplasty: a time-related phenomenon. A quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181203

Major clinical events after coronary stenting. The multicenter registry of acute and elective Gianturco-Roubin stent placement. The Gianturco-Roubin Intracoronary Stent Investigator Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181203

Low molecular weight heparin in prevention of restenosis after angioplasty. Results of Enoxaparin Restenosis (ERA) Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181203

Double-blind, randomized, controlled trial of fish oil supplements in prevention of recurrence of stenosis after coronary angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181203

Recognition of restenosis: can patients be defined in whom the exercise-ECG result makes angiographic restudy unnecessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181203

Relation between Myocardial Blood Flow and the Severity of Coronary-Artery Stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181203

7 January 2021

Coronary flow reserve as a physiologic measure of stenosis severity

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181203

7 January 2021

Does visual interpretation of the coronary arteriogram predict the physiologic importance of a coronary stenosis?

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181203

7 January 2021

Histologic findings in specimens obtained by percutaneous directional coronary atherectomy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181203

7 January 2021

Analysis of atherectomy specimens

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181203

7 January 2021

Restenosis after percutaneous transluminal coronary angioplasty: pathologic observations in 20 patients

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181203

7 January 2021

Restenosis after percutaneous transluminal coronary angioplasty--a histopathological study using autopsied hearts.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181203

7 January 2021

Percutaneous coronary angioscopy in patients with restenosis after coronary angioplasty

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181203

7 January 2021

Restenosis after percutaneous transluminal coronary angioplasty (PTCA): A report from the PTCA registry of the national heart, lung, and blood institute

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181203

7 January 2021

Restenosis after successful percutaneous transluminal coronary angioplasty: the Montreal Heart Institute experience

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181203

7 January 2021

Restenosis after percutaneous transluminal coronary angioplasty: the Emory University Hospital experience

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181203

7 January 2021

Restenosis after successful percutaneous transluminal coronary angioplasty: serial angiographic follow-up of 229 patients

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181203

7 January 2021

Coronary angioplasty: clinical and angiographic follow-up

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181203

7 January 2021

Recurrent restenosis after transluminal coronary angioplasty--dilatation or surgery?

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181203

7 January 2021

A comparison of directional atherectomy with coronary angioplasty in patients with coronary artery disease. The CAVEAT Study Group

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181203

7 January 2021

Restenosis after coronary angioplasty: an overview

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181203

7 January 2021

Aggressive clinical pattern of angina at restenosis following coronary angioplasty in unstable angina

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181203

7 January 2021

Clinical characteristics and angiographic follow-up of patients undergoing early or late repeat dilation for a first restenosis

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181203

7 January 2021

Can restenosis after coronary angioplasty be predicted from clinical variables?

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181203

7 January 2021

Detection of restenosis after elective percutaneous transluminal coronary angioplasty using the exercise treadmill test

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181203

7 January 2021

Efficacy of repeat percutaneous transluminal coronary angioplasty for coronary restenosis

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181203

7 January 2021

Angiographic findings when chest pain recurs after successful percutaneous transluminal coronary angioplasty

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181203

7 January 2021

Intracoronary ultrasound predictors of adverse outcomes after coronary artery interventions

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181203

7 January 2021

Stress thallium-201 imaging after coronary angioplasty predicts restenosis and recurrent symptoms

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181203

7 January 2021

Usefulness of dobutamine echocardiography for detecting restenosis after percutaneous transluminal coronary angioplasty

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181203

7 January 2021

Repeat coronary angioplasty

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181203

7 January 2021

Repeat percutaneous transluminal coronary angioplasty and predictors of recurrent restenosis

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181203

7 January 2021

Repeat coronary angioplasty for restenosis: results and predictors of follow-up clinical events

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181203

7 January 2021

Repeat coronary angioplasty: correlates of a second restenosis

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181203

7 January 2021

Outcome in patients with recurrent restenosis after percutaneous transluminal balloon angioplasty

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181203

7 January 2021

Repeat coronary angioplasty as treatment for restenosis

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181203

7 January 2021

Repeat coronary angioplasty: efficacy of a third angioplasty for a second restenosis

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181203

7 January 2021

Results of directional atherectomy of primary atheromatous and restenosis lesions in coronary arteries and saphenous vein grafts

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181203

7 January 2021

Analysis of late lumen narrowing after excimer laser-facilitated coronary angioplasty

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181203

7 January 2021

Percutaneous excimer laser coronary angioplasty: results in the first consecutive 3,000 patients. The ELCA Investigators

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181203

7 January 2021

Wiktor stent implantation in patients with restenosis following balloon angioplasty of a native coronary artery

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181203

7 January 2021

A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181203

7 January 2021

A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181203

7 January 2021

Caveats about Elective Coronary Stenting

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181203

7 January 2021

Initial management and long-term clinical outcome of restenosis after initially successful percutaneous transluminal coronary angioplasty

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181203

7 January 2021

Midterm outcome of patients with asymptomatic restenosis after coronary balloon angioplasty

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181203

7 January 2021

Long-term outcome of patients with asymptomatic restenosis after percutaneous transluminal coronary angioplasty

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181203

7 January 2021

Coumadin and aspirin in prevention of recurrence after transluminal coronary angioplasty: a randomized study

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181203

7 January 2021

A meta-analysis of randomized trials of calcium antagonists to reduce restenosis after coronary angioplasty

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181203

7 January 2021

Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for reduction of clinical restenosis: results at six months

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181203

7 January 2021

Potential role of human cytomegalovirus and p53 interaction in coronary restenosis

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181203

7 January 2021

The basis of molecular strategies for treating coronary restenosis after angioplasty

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181203

7 January 2021

A comparison of directional atherectomy with balloon angioplasty for lesions of the left anterior descending coronary artery

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181203

7 January 2021

Verapamil treatment after coronary angioplasty in patients at high risk of recurrent stenosis

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181203

7 January 2021

A controlled trial of corticosteroids to prevent restenosis after coronary angioplasty. M-HEART Group

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181203

7 January 2021

Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181203

7 January 2021

Randomised trial of fish oil for prevention of restenosis after coronary angioplasty

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181203

7 January 2021

A prospective, randomized, and double-blind trial on the effect of fish oil on the incidence of restenosis following PTCA

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181203

7 January 2021

Effects of low-dose aspirin on restenosis after coronary angioplasty

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181203

7 January 2021

Effect of nifedipine on recurrent stenosis after percutaneous transluminal coronary angioplasty

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181203

7 January 2021

Effect of short-term prostacyclin administration on restenosis after percutaneous transluminal coronary angioplasty

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181203

7 January 2021

Effects of diltiazem on complications and restenosis after coronary angioplasty

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181203

7 January 2021

Effect of 18- to 24-hour heparin administration for prevention of restenosis after uncomplicated coronary angioplasty

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181203

7 January 2021

Immediate and 6-month follow-up results of coronary angioplasty for restenosis: analysis of factors predicting recurrent clinical restenosis

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181203

7 January 2021

Percutaneous transluminal coronary angioplasty more than twice for the same coronary lesion

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181203

7 January 2021

Treatment of recurrent restenosis with repeat percutaneous transluminal coronary angioplasty

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181203

7 January 2021

Identifiers

DOI

10.1002/CLC.4960181203

1 reference

25 September 2017

1 reference